Canakinumab

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Canakinumab
Treatment and conditionWhere it standsTrials
Canakinumab for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Canakinumab for myocardial infarctionPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1